0001213900-20-028423.txt : 20200925 0001213900-20-028423.hdr.sgml : 20200925 20200925151844 ACCESSION NUMBER: 0001213900-20-028423 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200821 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200925 DATE AS OF CHANGE: 20200925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bespoke Extracts, Inc. CENTRAL INDEX KEY: 0001409197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204743354 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-52759 FILM NUMBER: 201199528 BUSINESS ADDRESS: STREET 1: 323 SUNNY ISLES BOULEVARD STREET 2: SUITE 700 CITY: SUNNY ISLES STATE: FL ZIP: 33160 BUSINESS PHONE: 855-633-3738 MAIL ADDRESS: STREET 1: 323 SUNNY ISLES BOULEVARD STREET 2: SUITE 700 CITY: SUNNY ISLES STATE: FL ZIP: 33160 FORMER COMPANY: FORMER CONFORMED NAME: DiMi Telematics International, Inc. DATE OF NAME CHANGE: 20120319 FORMER COMPANY: FORMER CONFORMED NAME: FIRST QUANTUM VENTURES INC DATE OF NAME CHANGE: 20071106 FORMER COMPANY: FORMER CONFORMED NAME: First Quantum Ventures Inc DATE OF NAME CHANGE: 20070808 8-K/A 1 ea127407-8ka_bespoke.htm AMENDMENT NO. 1 TO FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 21, 2020

Bespoke Extracts, Inc.

(Exact name of registrant as specified in its charter)

Nevada		000-52759		20-4743354
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

323 Sunny Isles Boulevard, Suite 700

Sunny Isles Beach, FL 33160

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (855) 633-3738

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

This Current Report on Form 8-K/A amends and restates the Current Report on Form 8-K filed by Bespoke Extracts, Inc. on August 26, 2020.

Item 1.01 Entry into a Material Definitive Agreement.

On August 21, 2020, Bespoke Extracts, Inc. (the “Company”) entered into an amendment (the “Debenture Amendment No. 2”) to the original issue discount convertible debenture, dated December 24, 2019, as amended by amendment No. 1 thereto, dated May 28, 2020, between the Company and The Vantage Group Ltd. (“Vantage”), the holder of the debenture. Pursuant to the Debenture Amendment No. 2, the maturity date of the debenture was extended to November 30, 2020. Vantage is owned by Lyle Hauser, formerly a significant stockholder of the Company.

The foregoing description of the Debenture Amendment No. 2 is qualified by reference to the full text of such document, which is filed as an exhibit to this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	Description

10.1	Amendment No. 2 to Debenture (previously filed)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Bespoke Extracts, Inc.

Date: September 25, 2020	By:	/s/ Danil Pollack
		Danil Pollack Chief Executive Officer